Download our Mission Package
JDRF research focuses on key therapies that hold significant promise in turning Type One into Type None.
Recent Press Releases
- Two-year $300 Million Extension of the Special Diabetes Program Allows for the Continuation of Promising Ongoing Clinical Trials
- JDRF Announces New Partnership with the European Foundation for the Study of Diabetes and Eli Lilly and Company to Fund Novel Diabetes Research
- JDRF Supports Janssen’s Disease Interception Approach to Prevent the Clinical Onset of Type 1 Diabetes
- JDRF Congratulates Medtronic Inc. – Next Generation AP System Launches
- JDRF Mourns the Passing of Dr. Hanna Abboud
- Jeremy’s Tips for Safe Drinking with Diabetes
- 7 Quick Low Carb Breakfast Ideas
- “Replace-BG” Study Gathers Evidence for Insulin Dosing Off CGM Data (!)
- How to Safely Go Beast-Mode in Your Type 1 Workout
- Aiming for Smooth Travel with Diabetes
For all other inquiries, please contact JDRF Public Information.
Director, Public Relations
Office: (212) 479-7667